Cargando…

Rationale and Design of the Vitamin D and Type 2 Diabetes (D2d) Study: A Diabetes Prevention Trial

OBJECTIVE: Observational studies suggest that vitamin D may lower the risk of type 2 diabetes. However, data from long-term trials are lacking. The Vitamin D and Type 2 Diabetes (D2d) study is a randomized clinical trial designed to examine whether a causal relationship exists between vitamin D supp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pittas, Anastassios G., Dawson-Hughes, Bess, Sheehan, Patricia R., Rosen, Clifford J., Ware, James H., Knowler, William C., Staten, Myrlene A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Emerging Technologies and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237973/ https://www.ncbi.nlm.nih.gov/pubmed/25205139 http://dx.doi.org/10.2337/dc14-1005

Ejemplares similares

Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study
por: Dawson-Hughes, Bess, et al.
Publicado: (2020)

Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D?
por: Pittas, Anastassios G, et al.
Publicado: (2020)

Response to Comment on Dawson-Hughes et al. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916–2922
por: Dawson-Hughes, Bess, et al.
Publicado: (2021)

Response to Letter to the Editor from Dalan: “Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D?”
por: Pittas, Anastassios G, et al.
Publicado: (2020)

Vitamin D for the treatment of painful diabetic neuropathy
por: Basit, Abdul, et al.
Publicado: (2016)

Vitamin D Supplementation in Patients With Type 2 Diabetes: The Vitamin D for Established Type 2 Diabetes (DDM2) Study
por: Angellotti, Edith, et al.
Publicado: (2018)

Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590–1599
por: LeBlanc, Erin S., et al.
Publicado: (2019)

Metabolic Effects of Exercise Training Among Fitness-Nonresponsive Patients With Type 2 Diabetes: The HART-D Study
por: Pandey, Ambarish, et al.
Publicado: (2015)

Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study
por: Wieringa, Thomas H, et al.
Publicado: (2018)

Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women
por: Pittas, Anastassios G., et al.
Publicado: (2010)

Untangling the Gordian Knot of Vitamin D Supplementation and Type 2 Diabetes Prevention
por: Pittas, Anastassios G., et al.
Publicado: (2020)

Response to Comment on Lewis et al. Management of Hemoglobin Variants Detected Incidentally in HbA(1c) Testing: A Common Problem Currently Lacking a Standard Approach. Diabetes Care 2017;40:e8–e9
por: Lewis, Michael R., et al.
Publicado: (2017)

Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2014)

Plasma 25-Hydroxyvitamin D and Progression to Diabetes in Patients at Risk for Diabetes: An ancillary analysis in the Diabetes Prevention Program
por: Pittas, Anastassios G., et al.
Publicado: (2012)

Financial management of large, multi-center trials in a challenging funding milieu
por: Lovegreen, Olivia, et al.
Publicado: (2018)

Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes
por: Johnson, Karen C., et al.
Publicado: (2022)

Correction to: Safety and tolerability of high-dose daily vitamin D(3) supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes
por: Johnson, Karen C., et al.
Publicado: (2022)

Performance of the FreeStyle Libre Flash glucose monitoring system in patients with type 1 and 2 diabetes mellitus
por: Fokkert, M J, et al.
Publicado: (2017)

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp
por: Ly, Trang T., et al.
Publicado: (2014)

Safety of Nighttime 2-Hour Suspension of Basal Insulin in Pump-Treated Type 1 Diabetes Even in the Absence of Low Glucose
por: Sherr, Jennifer L., et al.
Publicado: (2014)

Restoring Insulin Secretion (RISE): Design of Studies of β-Cell Preservation in Prediabetes and Early Type 2 Diabetes Across the Life Span
Publicado: (2014)

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
por: Skyler, Jay S., et al.
Publicado: (2015)

Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development
por: Acevedo-Calado, Maria, et al.
Publicado: (2017)

Inhaled Formoterol Diminishes Insulin-Induced Hypoglycemia in Type 1 Diabetes
por: Belfort-DeAguiar, Renata D., et al.
Publicado: (2015)

Internet-delivered cognitive behaviour therapy for depression in people with diabetes: study protocol for a randomised controlled trial
por: Robins, Lisa, et al.
Publicado: (2015)

Prediction of diabetic kidney disease with machine learning algorithms, upon the initial diagnosis of type 2 diabetes mellitus
por: Allen, Angier, et al.
Publicado: (2022)

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
por: Ghazi, Tara, et al.
Publicado: (2014)

Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System
por: Castle, Jessica R., et al.
Publicado: (2015)

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
por: Orban, Tihamer, et al.
Publicado: (2014)

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes
por: Demeester, Simke, et al.
Publicado: (2015)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
por: Weiss, Tracey, et al.
Publicado: (2021)

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
por: Elleri, Daniela, et al.
Publicado: (2014)

Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria
por: McGill, Janet B, et al.
Publicado: (2022)

Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes
por: Singh, Sunny S, et al.
Publicado: (2020)

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
por: Hunt, Barnaby, et al.
Publicado: (2019)

Global diabetes burden: analysis of regional differences to improve diabetes care
por: Bour, Charline, et al.
Publicado: (2022)

Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using (18)F-FDG PET/MRI
por: Rasul, Sazan, et al.
Publicado: (2020)

Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
por: Ferrannini, Giulia, et al.
Publicado: (2015)

Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
por: Tao, Rui, et al.
Publicado: (2021)

Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
por: Horii, Takeshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u06ros60lvbac04nuhogc6hemu